Work

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years

Year: 2006

Type: article

Study design: Observational Study

Source: Blood Cells Molecules and Diseases

DOI: 10.1016/j.bcmd.2006.06.002

Authors: Rocco G. Piazza, Vera Magistroni, Anna Franceschino, Federica Andreoni, Lucia Tornaghi, Federica Colnaghi, Gianmarco Corneo, Enrico M. Pogliani, Carlo Gambacorti-Passerini

Institutions: Azienda Ospedaliera San Gerardo, University of Milano-Bicocca, Fondazione IRCCS Istituto Nazionale dei Tumori, McGill University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2005245904

FWCI: 0.405

Cites: 17

Cited by: 9

Related to: 10